Metropolis Healthcare Limited (NSE:METROPOLIS) Directors Insider Transactions
The Directors and Chief Executives of Metropolis Healthcare Limited (NSE:METROPOLIS) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Metropolis Healthcare Limited's shares in the stock market. Below table shows the list of insider transactions as reported by Metropolis Healthcare Limited to the NSE stock exchange.
An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.
Metropolis Healthcare Limited Directors/Insider Transactions Activity
List of Insider trades activity from Metropolis Healthcare Limited (METROPOLIS).
| Date | Director | Director's Title | Shares | Value | Note |
|---|---|---|---|---|---|
| 27 Jun 2025 | JP Morgan Bank International | Institution- Corporation | 343,968 | - | - |
| 17 Feb 2025 | UTI Equity Fund | Institution- Corporation | 54,670 | - | - |
| 21 Aug 2024 | Shah (Sushil Kanubhai) | Promoter | 25,000 | - | - |
| 19 Aug 2024 | Shah (Sushil Kanubhai) | Promoter | 25,000 | 635,740 | Sale at price 25.43 per share. |
| 16 Aug 2024 | Shah (Sushil Kanubhai) | Promoter | 40,000 | 982,004 | Sale at price 24.55 per share. |